Kim JH - Search Results

1

Clinical Characterization, Natural History, and Detailed Phenotyping of NMNAT1-Associated Leber Congenital Amaurosis.

Lee YJ, Jeong HC, Kim JH, Jo DH. Lee YJ, et al. Among authors: kim jh. Am J Ophthalmol. 2024 Dec 20:S0002-9394(24)00582-8. doi: 10.1016/j.ajo.2024.12.016. Online ahead of print. Am J Ophthalmol. 2024. PMID: 39710161

2

Genotype-Phenotype Correlations in 83 Korean X-linked Retinoschisis Patients: Impact of Retinoschisin 1 Secretion Profiles on Clinical Phenotypes.

Lee SJ, Jiang H, Jeong HC, Jo DH, Song HB, Gee HY, Lee KH, Kim JH. Lee SJ, et al. Among authors: kim jh. Ophthalmol Retina. 2024 Sep 16:S2468-6530(24)00431-7. doi: 10.1016/j.oret.2024.09.007. Online ahead of print. Ophthalmol Retina. 2024. PMID: 39293640

3

Development of New Solitary Retinoblastoma Tumors during and after Chemotherapy.

Choi WJ, Jo DH, Kang HJ, Shin HY, Yu YS, Kim JH. Choi WJ, et al. Among authors: kim jh. Korean J Ophthalmol. 2021 Feb;35(1):73-79. doi: 10.3341/kjo.2020.0115. Epub 2021 Feb 2. Korean J Ophthalmol. 2021. PMID: 33596616 Free PMC article.

4

Visual function restoration in a mouse model of Leber congenital amaurosis via therapeutic base editing.

Jo DH, Jang HK, Cho CS, Han JH, Ryu G, Jung Y, Bae S, Kim JH. Jo DH, et al. Among authors: kim jh. Mol Ther Nucleic Acids. 2022 Dec 5;31:16-27. doi: 10.1016/j.omtn.2022.11.021. eCollection 2023 Mar 14. Mol Ther Nucleic Acids. 2022. PMID: 36589710 Free PMC article.

5

Allelic hierarchy for USH2A influences auditory and visual phenotypes in South Korean patients.

Nam DW, Song YK, Kim JH, Lee EK, Park KH, Cha J, Choi BY, Lee JH, Oh SH, Jo DH, Lee SY. Nam DW, et al. Among authors: kim jh. Sci Rep. 2023 Nov 19;13(1):20239. doi: 10.1038/s41598-023-47166-w. Sci Rep. 2023. PMID: 37981655 Free PMC article.

6

How to overcome retinal neuropathy: the fight against angiogenesis-related blindness.

Jo DH, Kim JH, Kim JH. Jo DH, et al. Among authors: kim jh. Arch Pharm Res. 2010 Oct;33(10):1557-65. doi: 10.1007/s12272-010-1007-6. Epub 2010 Oct 30. Arch Pharm Res. 2010. PMID: 21052933 Review.

7

VEGF-binding aptides and the inhibition of choroidal and retinal neovascularization.

Jo DH, Kim S, Kim D, Kim JH, Jon S, Kim JH. Jo DH, et al. Among authors: kim d, kim s, kim jh. Biomaterials. 2014 Mar;35(9):3052-9. doi: 10.1016/j.biomaterials.2013.12.031. Epub 2014 Jan 2. Biomaterials. 2014. PMID: 24388818

8

A platform of integrative studies from in vitro to in vivo experiments: towards drug development for ischemic retinopathy.

Jo DH, Kim JH, Kim JH. Jo DH, et al. Among authors: kim jh. Biomed Pharmacother. 2015 Feb;69:367-73. doi: 10.1016/j.biopha.2014.12.027. Epub 2014 Dec 24. Biomed Pharmacother. 2015. PMID: 25661384 Review.

9

Application of genome engineering for treatment of retinal diseases.

Jo DH, Kim JH. Jo DH, et al. Among authors: kim jh. BMB Rep. 2018 Jul;51(7):315-316. doi: 10.5483/bmbrep.2018.51.7.130. BMB Rep. 2018. PMID: 29921414 Free PMC article.

10

Long-Term Effects of In Vivo Genome Editing in the Mouse Retina Using Campylobacter jejuni Cas9 Expressed via Adeno-Associated Virus.

Jo DH, Koo T, Cho CS, Kim JH, Kim JS, Kim JH. Jo DH, et al. Among authors: kim js, kim jh. Mol Ther. 2019 Jan 2;27(1):130-136. doi: 10.1016/j.ymthe.2018.10.009. Epub 2018 Oct 17. Mol Ther. 2019. PMID: 30470629 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,345 results

Search Page

Filters